Featured series 
Tag: Cancer
-
Health
First targeted therapy for melanoma brings hope
In a demonstration that even some of the most hard-to-treat tumors may one day succumb to therapies aimed at molecular “weak points,” researchers at Dana-Farber Cancer Institute report the first instance in which metastatic melanoma has been driven into remission by a targeted therapy.
-
Health
Late treatment with letrozole can reduce cancer recurrence risk
Treatment with the aromatase inhibitor letrozole (Femara) can reduce the risk of breast cancer recurrence even when initiated one to seven years after a course of tamoxifen therapy. The results of a study involving women originally in the placebo arm of an international trial of letrozole will appear in the Journal of Clinical Oncology and…
-
Campus & Community
Daffodil orders being taken until Feb. 29
The first flower of spring, the daffodil has long been a symbol of hope and renewal. It has also become a powerful tool in the American Cancer Society’s efforts to treat patients.
-
Campus & Community
Crimson still gritty in pink
Perhaps to the shock of the Union and Rensselaer women’s hockey teams, the color of the Crimson’s jerseys this past weekend (Feb. 8-9) failed to soften the club’s ferocious play. Donned in specifically designed pink jerseys for the Pink at the Rink campaign, the No. 1 nationally ranked Harvard squad shut out the visiting squads,…
-
Campus & Community
Daffodil Days, Harvard team up to fight cancer
The first flower of spring, the daffodil has long been a symbol of hope and renewal. It has also become a powerful tool in the American Cancer Society’s efforts to treat patients.
-
Health
Newly identified gene variants associated with prostate cancer risk
Three studies presenting newly identified genetic variants that are associated with increased susceptibility to prostate cancer were published recently (Feb. 10) on the advance online site of Nature Genetics. The 10 gene variants double the number of known variants associated with risk of the disease and are the result of genomewide association studies.
-
Health
Anxiety linked to overestimation of breast cancer risks
Elevated levels of anxiety may cause women with ductal carcinoma in situ (DCIS), the most common form of noninvasive breast cancer, to overestimate their risk of recurrence or dying from breast cancer, suggests a study led by researchers at Harvard-affiliated Dana-Farber Cancer Institute in Boston.
-
Campus & Community
Flower power: Daffodil Days, Harvard team up to fight cancer
The first flower of spring, the daffodil has long been a symbol of hope and renewal. It has also become a powerful tool in the American Cancer Society’s efforts to treat patients.
-
Health
Cancer stem cells can be targeted for destruction
It’s increasingly believed among scientists that nearly every cancer contains small populations of highly dangerous cells — cancer stem cells — that can initiate a cancer, drive its progression, and create endless copies of themselves. On the theory that targeting these cells might be an effective therapeutic strategy, researchers around the world have begun isolating…
-
Health
Research in brief
Major differences in protocols used to determine brain death; Harvard researchers achieve stem cell milestone; Consortium links chromosome abnormality to autism disorders; Blocking HIV infection; Oral osteoporosis meds appear to reduce the risk of jaw degradation; Six new genetic variants linked to heart-disease risk factor; Gene variation may elevate risk of liver tumor in some…
-
Campus & Community
Damon Runyon Cancer Research Foundation awards fellowships
The Damon Runyon Cancer Research Foundation has named three Harvard affiliates among its 17 new fellows. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.
-
Campus & Community
Cancer research pioneer Judah Folkman dies suddenly at 74
Cancer research pioneer Judah Folkman, the Andrus Professor of Pediatric Surgery and professor of cell biology at Harvard Medical School (HMS), died on Jan. 14 of a heart attack. Folkman, who was also the director of the Vascular Biology Program at Children’s Hospital Boston, was 74.
-
Health
Cancer drug activates adult stem cells
The use of a drug used in cancer treatment activates stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment…
-
Health
M. Judah Folkman, biomedical pioneer, dies at 74
One of Harvard Medical School’s (HMS) most forward-looking and innovative physician-scientists, M. Judah Folkman, died suddenly Monday (Jan. 14) after suffering a heart attack at the Denver International Airport in…
-
Health
Gene variation may elevate risk of liver tumor in patients with cirrhosis
A genetic variation appears to significantly increase the risk that individuals with cirrhosis of the liver will develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause…
-
Health
Microchip-based device can detect rare tumor cells in bloodstream
A team of investigators from the Massachusetts General Hospital (MGH) BioMicroElectroMechanical Systems (BioMEMS) Resource Center and the MGH Cancer Center has developed a microchip-based device that can isolate, enumerate and…
-
Health
Newly discovered type of cell death may end up inhibiting tumor growth
Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in physiology or medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.
-
Health
Blood stem cell’s roles could help clarify pathogenesis
No other stem cell is more thoroughly understood than the blood, or hematopoietic, stem cell. These occasional and rare cells, scattered sparingly throughout the marrow and capable of replenishing an entire blood system, have been the driving force behind successful bone marrow transplants for decades. Scientists, for the most part, have seen this as the…
-
Health
Consumption of some foods associated with decrease in ovarian cancer risk
New research from the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including non-herbal tea and broccoli, was associated with…
-
Health
Flavonoid-rich diet helps women decrease risk of ovarian cancer
New research out of the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli, was associated with a reduced risk of ovarian cancer. The researchers also found a decreased risk in women who consumed large amounts of the flavonoid luteolin, which…
-
Health
Obesity linked to higher prostate cancer mortality
Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the Dec. 15 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
-
Health
Obesity and overweight linked to higher prostate cancer mortality
Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the December 15, 2007 issue…
-
Health
Flavonoid-rich diet helps women decrease risk of ovarian cancer
New research out of the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli, was associated with a reduced risk of ovarian cancer.
-
Health
Genome study charts genetic landscape of lung cancer
An international team of scientists Sunday (Nov. 4) announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.
-
Health
Study paints genetic portrait of lung cancer
An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths. Appearing in…
-
Campus & Community
Newsmakers
Visiting scientist Frederick “Skip” Burkle, a senior fellow at the Harvard Humanitarian Initiative (HHI), was recently elected to the Institute of Medicine (IOM). New York Times columnist Maureen Dowd will deliver the Theodore H. White Lecture on Press and Politics Thursday (Oct. 25) at 6 p.m. in the John F. Kennedy Jr. Forum at the…
-
Health
Hormone therapy for prostate cancer puts heart at risk
Administering androgen deprivation therapy (ADT) prior to surgery and combining ADT with radiation therapy are popular approaches to treating men diagnosed with advanced or high-risk localized prostate cancer. However, the potentially negative side effects of ADT are just now being explored. Researchers at Brigham and Women’s Hospital (BWH) have found that ADT may increase the…
-
Campus & Community
Newsmakers
It was announced Wednesday (Oct. 10) that the prestigious 2007 IZA Prize in Labor Economics goes to Harvard’s Richard B. Freeman. He was praised by the Institute for the Study of Labor (IZA) in Germany for “fundamental contributions that have monumentally shaped modern labor economics.”
-
Health
Harvard researchers find longevity, restricted diet link
Researchers believe they’ve found the cellular link between extremely restricted diets and dramatically lengthened lifespan and hope to use the knowledge to develop new treatments for age-related diseases.
-
Nation & World
Global momentum for smoke-free society
In a perspective article in the April 12 issue of The New England Journal of Medicine (NEJM), researchers from the Harvard School of Public Health (HSPH) and the Association of European Cancer Leagues describe the growing momentum for indoor smoking bans in countries across the globe. They identify Ireland’s pioneering 2004 comprehensive indoor smoking ban…